Therapeutically active compounds and their methods of use

US9751863B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9751863-B2
Application numberUS-201615229011-A
CountryUS
Kind codeB2
Filing dateAug 4, 2016
Priority dateAug 5, 2015
Publication dateSep 5, 2017
Grant dateSep 5, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are compounds useful for treating cancer and methods of making the compounds and intermediates described herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a compound having the formula (I): wherein ring A is pyridinyl substituted with trifluoromethyl, comprising reacting a compound of formula (II): wherein R is alkyl, alkenyl or alkynyl; with  (biuret) in the presence of a dehydrating agent, wherein the dehydrating agent comprises (i) trimethyl orthoformate and a catalytic amount of trifluoroacetic acid or (ii) titanium(IV) ethoxide. 2. A method of preparing a compound of formula (Ia): comprising reacting a compound of formula (IIa): with  with (biuret) in the presence of a dehydrating reagent to provide the compound of formula (Ia), wherein the dehydrating agent comprises (i) trimethyl orthoformate and a catalytic amount of trifluoroacetic acid or (ii) titanium(IV) ethoxide. 3. The method of claim 2 , wherein the reaction is in the presence of a base. 4. The method of claim 3 , wherein the base is sodium ethoxide. 5. The method of claim 1 , wherein the compound of formula (II) is prepared by reacting a compound of formula (III) with an acid halide and an alcohol. 6. The method of claim 2 , wherein the compound of formula (IIa) is prepared by reacting a compound of formula (IIIa): with hydrogen chloride and methanol. 7. The method of claim 1 , further comprising halogenating the compound of formula (I) to give a compound of formula (IV) wherein X is a halogen. 8. The method of claim 2 , further comprising reacting the compound of formula (Ia) with benzyltriethylammonium chloride and POCl 3 to give a compound of formula (IVb) 9. The method of claim 8 , further comprising reacting the compound of formula (IVb) with a compound of formula (Va) to give a compound of formula (VIb) 10. A method of preparing a compound of formula (VIIIa) comprising a) reacting compound (Ia) with benzyltriethylammonium chloride and POCl 3 to obtain compound (IVb) b) reacting compound (IVb) with 2-(trifluoromethyl)pyridin-4-amine to obtain compound (VIb) and c) reacting compound (VIb) with 1-amino-2-methylpropan-2-ol to obtain the compound of formula (VIIIa), wherein compound (Ia) is prepared by reacting with in the presence of a dehydrating reagent, wherein the dehydrating agent comprises (i) trimethyl orthoformate and a catalytic amount of trifluoroacetic acid or (ii) titanium(IV) ethoxide. 11. The method of claim 10 , wherein step a) comprises heating to about 95-98° C. for about 18 hours. 12. The method of claim 10 , wherein step b) comprises aging at about 20° C. for about 3 h and then heating to about 60-65° C. for about 15.5 h. 13. The method of claim 10 , wherein step b) is conducted in methyltetrahydrofuran. 14. The method of claim 10 , wherein step c) is conducted at about 20-30° C. 15. The method of claim 10 , wherein step c) is conducted in presence of diisopropylethylamine. 16. The method of claim 10 , wherein the reaction of (IIa) is conducted in the presence of a base. 17. The method of claim 16 , wherein the base is sodium ethoxide.

Assignees

Inventors

Classifications

  • C07D401/14Primary

    containing three or more hetero rings · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9751863B2 cover?
Provided are compounds useful for treating cancer and methods of making the compounds and intermediates described herein.
Who is the assignee on this patent?
Agios Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07D401/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).